MYLET JOHANNA (Senior Vice President, Finance) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2024ACC: 0000950170-24-024986
Officer· Senior Vice President, Finance
Since Jul 2020
+174.35K
Net shares
Net buyer
$74.7K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
192.44K acquired · 18.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+80.74K
Price / share
—
Trade value
—
% of position
44.0%
3/1/2024
183.63K→264.37K
Common Stock
Direct
Shares
−18.09K
Price / share
$4.13
Trade value
$74.72K
% of position
6.8%
3/1/2024
264.37K→246.28K
Total
Net shares
+62.65K
Net value
-$74.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | A · Award | +80.74K | — | — | 44.0% | 183.63K | 264.37K |
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −18.09K | $4.13 | $74.72K | 6.8% | 264.37K | 246.28K |
| Total | +62.65K | -$74.72K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
111.70K shares
Shares
+111.70K
Strike price
4.13
Held after
111.70K
Exercisable
—
3/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock111.70K shares | 3/1/2024 | A · Award | +111.70K | 4.13 | — | 111.70K |